Results 261 to 270 of about 37,793 (319)

Comparative Safety Profiles of Ocrelizumab and Rituximab in Multiple Sclerosis Treatment Using Real‐World Evidence

open access: yesAnnals of Neurology, EarlyView.
Objective The objective of this study was to compare the long‐term safety profiles of ocrelizumab and rituximab in persons with multiple sclerosis (MS). Methods Using retrospective data from the University of California (UC) Health System, we simulated a target clinical trial. The primary cohort from UC San Francisco (UCSF) and a validation cohort from
Gabriel Cerono   +3 more
wiley   +1 more source

Retraction Note: Have international remittance inflows degraded environmental quality? A carbon emission mitigation analysis for Ghana. [PDF]

open access: yesEnviron Sci Pollut Res Int
Li K   +11 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy